Institute of Pharmacology and Toxicology and Key Laboratory of Nanopharmacology and Nanotoxicology, Academy of Beijing Medical Sciences, Beijing 100850, China.
Institute of Pharmacology and Toxicology and Key Laboratory of Nanopharmacology and Nanotoxicology, Academy of Beijing Medical Sciences, Beijing 100850, China.
Biomaterials. 2014 Nov;35(33):9208-23. doi: 10.1016/j.biomaterials.2014.07.033. Epub 2014 Aug 10.
Gastric cancer stem cells (CSCs) play a crucial role in the initiation, development, relapse and metastasis of gastric cancer because they are resistant to a standard chemotherapy and the residual CSCs are able to proliferate indefinitely. Therefore, eradication of this cell population is a primary objective in gastric cancer therapy. Here, we report a gastric CSCs-specifically targeting drug delivery system (SAL-SWNT-CHI-HA complexes) based on chitosan(CHI) coated single wall carbon nanotubes (SWNTs) loaded with salinomycin (SAL) functionalized with hyaluronic acid (HA) can selectively eliminate gastric CSCs. Gastric CSCs were identified as CD44+ cells and cultured in serum-free medium. SAL-SWNT-CHI-HA complexes were capable of inhibiting the self-renewal capacity of CD44+ population, and decrease mammosphere- and colon-formation of CSCs. In addition, the migration and invasion of gastric CSCs were significantly blocked by SAL-SWNT-CHI-HA complexes. Quantitative and qualitative analysis of cellular uptake demonstrated that HA functionalization facilitated the uptake of SWNTs in gastric CSCs while free HA competitively inhibited cellular uptake of SAL-SWNT-CHI-HA delivery system, revealing the mechanism of CD44 receptor-mediated endocytosis. The SAL-SWNT-CHI-HA complexes showed the strongest antitumor efficacy in gastric CSCs by inducing apoptosis, and in CSCs mammospheres by penetrating deeply into the core. Taken altogether, our studies demonstrated that this gastric CSCs-targeted SAL-SWNT-CHI-HA complexes would provide a potential strategy to selectively target and efficiently eradicate gastric CSCs, which is promising to overcome the recurrence and metastasis of gastric cancer and improve gastric cancer treatment.
胃癌干细胞(CSCs)在胃癌的发生、发展、复发和转移中起着关键作用,因为它们对标准化疗具有耐药性,而残留的 CSCs 能够无限增殖。因此,根除这种细胞群体是胃癌治疗的主要目标。在这里,我们报告了一种基于壳聚糖(CHI)包覆的负载有萨利霉素(SAL)的单壁碳纳米管(SWNTs)的胃癌 CSCs 特异性靶向药物传递系统(SAL-SWNT-CHI-HA 复合物),该复合物可以特异性地消除胃癌 CSCs。胃癌 CSCs 被鉴定为 CD44+细胞,并在无血清培养基中培养。SAL-SWNT-CHI-HA 复合物能够抑制 CD44+群体的自我更新能力,并减少 CSCs 的类乳腺球和结肠形成。此外,SAL-SWNT-CHI-HA 复合物显著抑制了胃癌 CSCs 的迁移和侵袭。细胞摄取的定量和定性分析表明,HA 功能化促进了 SWNTs 在胃癌 CSCs 中的摄取,而游离 HA 则竞争性抑制了 SAL-SWNT-CHI-HA 传递系统的细胞摄取,揭示了 CD44 受体介导的内吞作用的机制。SAL-SWNT-CHI-HA 复合物通过诱导凋亡在胃癌 CSCs 中表现出最强的抗肿瘤功效,并在 CSCs 类乳腺球中深入渗透。总之,我们的研究表明,这种胃癌 CSCs 靶向的 SAL-SWNT-CHI-HA 复合物为选择性靶向和有效根除胃癌 CSCs 提供了一种潜在策略,有望克服胃癌的复发和转移,并改善胃癌的治疗效果。